Targeting KRAS reprograms a Treg-dominant immunosuppressive microenvironment and sensitizes KRAS-mutant gastric adenocarcinoma to CTLA-4 immunotherapy.
Xiao-Huan Tang
Pei-Yao Yang
Xiao-Yong Guo
Shu-Hua Wei
Xiao-Jing Cheng
Meng-Yuan Li
Yi Bao
S. Nomura
Yu Sun
Long-Tao Huangfu
Xiao-Fang Xing
Yong-Ning Jia
Shangnon Fei
Xiang-Yu Gao
Chuanhui Han
Zi-Yu Li
Medicine